Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 18-Jun-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 26)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
18-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$207  View Abstract
15-Jun-13S&P Capital IQ Quantitative ReportN/AAffymax Inc6$69  View Abstract
14-Jun-13Wright ReportsN/AWright Industry Averages: Pharmaceuticals & Biotechnology (United States)77$885.50  View Abstract
14-Jun-13Wright ReportsN/AWright Industry Averages: Pharmaceuticals & Biotechnology (North America)78$897  View Abstract
14-Jun-13Wright ReportsN/AWright Industry Averages: Pharmaceuticals & Biotechnology (Global)105$1207.50  View Abstract
14-Jun-13Ford Investor Services, Inc.N/AIndustry Value Graph: ACOR , AFFY , BSTC , IMUC , TELK -- DRUGS3$34.50  View Abstract
14-Jun-13Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AFFYMAX INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
14-Jun-13Ford Investor Services, Inc.N/AValue Graph: AFFYMAX -- AFFY1$11.50  View Abstract
13-Jun-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for AFFY11$126.50  View Abstract
11-Jun-13Wright ReportsN/AWright Investors Service Comprehensive Report for Affymax, Inc.41$471.50  View Abstract
Next 16
Independent Reports (Showing 1 to 10 of 26)
Release
Date [down]		 Contributor Author Title Pages Price More Info
18-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$207View Abstract
15-Jun-13S&P Capital IQ Quantitative ReportN/AAffymax Inc6$69View Abstract
14-Jun-13Wright ReportsN/AWright Industry Averages: Pharmaceuticals & Biotechnology (United States)77$885.50View Abstract
14-Jun-13Wright ReportsN/AWright Industry Averages: Pharmaceuticals & Biotechnology (North America)78$897View Abstract
14-Jun-13Wright ReportsN/AWright Industry Averages: Pharmaceuticals & Biotechnology (Global)105$1207.50View Abstract
14-Jun-13Ford Investor Services, Inc.N/AIndustry Value Graph: ACOR , AFFY , BSTC , IMUC , TELK -- DRUGS3$34.50View Abstract
14-Jun-13Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AFFYMAX INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
14-Jun-13Ford Investor Services, Inc.N/AValue Graph: AFFYMAX -- AFFY1$11.50View Abstract
13-Jun-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for AFFY11$126.50View Abstract
11-Jun-13Wright ReportsN/AWright Investors Service Comprehensive Report for Affymax, Inc.41$471.50View Abstract
Next 16

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.